EP0660710A4 - Zusammensetzungen von n-(phosphonoacetyl)-l-asparaginsäure und verfahren für ihre verwendung als antivirale mittel mit breitem wirkungsspektrum. - Google Patents

Zusammensetzungen von n-(phosphonoacetyl)-l-asparaginsäure und verfahren für ihre verwendung als antivirale mittel mit breitem wirkungsspektrum.

Info

Publication number
EP0660710A4
EP0660710A4 EP19930909132 EP93909132A EP0660710A4 EP 0660710 A4 EP0660710 A4 EP 0660710A4 EP 19930909132 EP19930909132 EP 19930909132 EP 93909132 A EP93909132 A EP 93909132A EP 0660710 A4 EP0660710 A4 EP 0660710A4
Authority
EP
European Patent Office
Prior art keywords
phosphonoacetyl
compositions
methods
aspartic acid
broad spectrum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19930909132
Other languages
English (en)
French (fr)
Other versions
EP0660710A1 (de
Inventor
Herbert A Blough
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune LLC
Original Assignee
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/032,234 external-priority patent/US5491135A/en
Application filed by MedImmune LLC filed Critical MedImmune LLC
Publication of EP0660710A4 publication Critical patent/EP0660710A4/de
Publication of EP0660710A1 publication Critical patent/EP0660710A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP93909132A 1992-03-18 1993-03-18 Zusammensetzungen von n-(phosphonoacetyl)-l-asparaginsäure und verfahren für ihre verwendung als antivirale mittel mit breitem wirkungsspektrum Withdrawn EP0660710A1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US85345492A 1992-03-18 1992-03-18
US853454 1992-03-18
US08/032,234 US5491135A (en) 1992-03-18 1993-03-17 Compositions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals
PCT/US1993/002432 WO1993018763A1 (en) 1992-03-18 1993-03-18 Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals
US32234 1998-02-27

Publications (2)

Publication Number Publication Date
EP0660710A4 true EP0660710A4 (de) 1995-03-02
EP0660710A1 EP0660710A1 (de) 1995-07-05

Family

ID=26708159

Family Applications (1)

Application Number Title Priority Date Filing Date
EP93909132A Withdrawn EP0660710A1 (de) 1992-03-18 1993-03-18 Zusammensetzungen von n-(phosphonoacetyl)-l-asparaginsäure und verfahren für ihre verwendung als antivirale mittel mit breitem wirkungsspektrum

Country Status (10)

Country Link
EP (1) EP0660710A1 (de)
JP (1) JPH07507770A (de)
CN (1) CN1080853A (de)
AU (1) AU3965993A (de)
BR (1) BR9306123A (de)
CA (1) CA2109435C (de)
IL (1) IL105090A (de)
IS (1) IS3987A (de)
MX (1) MX9301527A (de)
WO (1) WO1993018763A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
PT1030839E (pt) 1997-11-10 2004-05-31 Searle & Co Utilizacao de iminoacucares para tratar a resistencia a multifarmacos
DE69932154T2 (de) 1998-02-12 2007-05-31 G.D. Searle Llc, Chicago Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
ATE402701T1 (de) 1999-02-12 2008-08-15 United Therapeutics Corp N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
JP2003505501A (ja) 1999-02-12 2003-02-12 ジー・ディー・サール・アンド・カンパニー 肝炎ウィルス感染の処置のためのグルカミン化合物
AU2012101A (en) * 1999-12-20 2001-07-03 New Pharma Research Sweden Ab Veterinary compositions
DE10138912A1 (de) * 2001-08-08 2003-02-27 Medinnova Ges Med Innovationen Verwendung von Wirksubstanzen zur Prophylaxe und/oder Therapie von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen
DE10343365A1 (de) * 2003-09-17 2005-04-14 Biosphings Ag Pharmazeutische Formulierungen von Xanthogenaten und Hemmstoffen der viralen Nukleinsäurereplikation
US8236768B2 (en) 2008-10-03 2012-08-07 3B Pharmaceuticals, Inc. Topical antiviral formulations
WO2021189444A1 (zh) * 2020-03-24 2021-09-30 中国人民解放军海军军医大学 利福霉素类抗生素在制备抗黄热病毒感染药物中的应用
CN111317733B (zh) * 2020-03-24 2022-07-12 中国人民解放军海军军医大学 利福霉素类抗生素在制备抗黄热病毒感染药物中的应用
CN111419839A (zh) * 2020-03-31 2020-07-17 远见生物科技（上海）有限公司 利福霉素的新用途
US20230147364A1 (en) * 2020-04-30 2023-05-11 Kyoto University Prophylactic or therapeutic agent for rna virus-related diseases
EP4313150A1 (de) * 2021-03-26 2024-02-07 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Kombination von pyrimidinbiosynthesehemmern zur verwendung bei der behandlung von virusinfektionen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178306A (en) * 1978-08-10 1979-12-11 Parsons Jack L Preparation of N-(phosphonoacetyl)-L-aspartic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
CA2109435A1 (en) 1993-09-19
EP0660710A1 (de) 1995-07-05
IS3987A (is) 1993-09-19
BR9306123A (pt) 1997-08-26
IL105090A0 (en) 1994-08-26
IL105090A (en) 1998-08-16
CA2109435C (en) 1997-03-11
AU3965993A (en) 1993-10-21
CN1080853A (zh) 1994-01-19
JPH07507770A (ja) 1995-08-31
MX9301527A (es) 1994-02-28
WO1993018763A1 (en) 1993-09-30

Similar Documents

Publication Publication Date Title
EP0660710A4 (de) Zusammensetzungen von n-(phosphonoacetyl)-l-asparaginsäure und verfahren für ihre verwendung als antivirale mittel mit breitem wirkungsspektrum.
IL112495A0 (en) Phenylacetic acid derivatives, their preparation and compositions containing them
ZA931934B (en) Compostitions of N-(phosphonoacetyl)-L-aspartic acid and methods of their use as broad spectrum antivirals
ZA9510138B (en) Cosmetic compositions containing betullnic acid
CA2130116A1 (en) Aminoacetylmercaptoacetylamide Derivatives Useful as Inhibitors of Enkephalinase and Ace
ZA935532B (en) Crystalline amifostine compositions and methods for the preparation and use of same
AU7694787A (en) Compositions for the prolonged action of anti-plaque agents
GB2216119B (en) Preparation of organometallic amide compositions
NZ212436A (en) D,l-glutamic and d,l-aspartic acid derivatives and pharmaceutical compositions
HUT41957A (en) Insecticide compositions containing aryl-pyridon derivatives as active agents and process for producing the active agents
PT78341B (en) Process for the preparation of new 3-(3,4-di-hydroxyphenyl)-alanine phosphorilates derivatives and compositions for tanning containing then
AU2392392A (en) Novel benzopyrido piperylidene compounds, compositions, methods of manufacture and methods of use
PH24326A (en) Substituted 3,4-dihydro-2h-benzopyrans,pharmaceutical compositions containing same and method of use thereof
HUT41206A (en) Fungicide compositions containing alpha-oximino-alpha-carbamoyl-acetonitril derivatives as active agents and process for producing the active agents
DE3463038D1 (en) Titanium chelates and compositions containing these chelates
HUT43573A (en) Process for producing azolyl-cyclopropyl-ethanol derivatives and compositions containing them as active agents
HUT41764A (en) Herbicide compositions containing 5-amino-4-cyano-1-pyridyl-pyrazole derivatives as active agents and process for producing the active agents
HUT44129A (en) Herbicide compositions containing 1-aryl-pyrazol derivatives as active components and process for producing 1-aryl-pyrazol derivatives
PH21556A (en) Phenyl nonatetraenoic acid derivatives, pharmaceutical compositions containing the same and method of use thereof
HUT41376A (en) Insecticide compositions containing phenyl-hidrazine derivatives as active agents and process for producing the active agents
NZ210716A (en) Pyridyloxytrifluoromethanesulphonanilide derivatives and compositions for protecting keratin from insects
AU3454984A (en) 1,z-dithiolanes and pharmaceutical compositions
EP0206127A3 (en) Co-vulcanizable compositions of fluoroelastomers
HUT41961A (en) Herbicide compositions containing thienyl-sulfonyl-guanidine derivatives as active agents and process for producing the active agents
PL320294A1 (en) Derivatives of 6-methoxy-1h-benzotriazolo-5-carboxylamide, methods of obtaining them and pharmaceutic compositions containing such derivatives

Legal Events

Date Code Title Description
A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19941017

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19980526

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19981205